High Dose Chemotherapy and Autologous Transplant for Breast Cancer

Stanford University

Status and phase: Unknown; Phase 2

Conditions: Graft vs Host Disease

Treatments: Procedure: high dose chemo and auto hematopoietic cell transplant

Study type: Interventional

Funder types: Other

Identifiers

NCT00186641

BMT42

Details and patient eligibility

About

To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stage II, III or IV breast cancer
• chemosensitive
• adequate organ function

Exclusion criteria

• prior transplant,
• life threatening disease
• brain metastases

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)